196 related articles for article (PubMed ID: 4940021)
1. Immunotherapy of cancer: immunospecific rejection of tumors in recipients of neuraminidase-treated tumor cells plus BCG.
Simmons RL; Rios A
Science; 1971 Nov; 174(4009):591-3. PubMed ID: 4940021
[TBL] [Abstract][Full Text] [Related]
2. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
Simmons RL; Rios A
Ann Surg; 1972 Aug; 176(2):188-94. PubMed ID: 4562008
[No Abstract] [Full Text] [Related]
3. Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
Rios A; Simmons RL
Cancer Res; 1972 Jan; 32(1):16-21. PubMed ID: 4550256
[No Abstract] [Full Text] [Related]
4. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.
Simmons RL; Rios A; Lundgren G; Ray PK; McKhann CF; Haywood GR
Surgery; 1971 Jul; 70(1):38-46. PubMed ID: 5092115
[No Abstract] [Full Text] [Related]
5. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
Simmons RL; Rios A
Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
[No Abstract] [Full Text] [Related]
6. Combined use of BCG and neuraminidase in experimental tumor immunotherapy.
Simmons RL; Rios A
Surg Forum; 1971; 22():99-101. PubMed ID: 4941334
[No Abstract] [Full Text] [Related]
7. Effect of neuraminidase on growth of a 3-methylcholanthrene-induced fibrosarcoma in normal and immunosuppressed syngeneic mice.
Simmons RL; Rios A; Ray PK; Lundgren G
J Natl Cancer Inst; 1971 Nov; 47(5):1087-94. PubMed ID: 5123336
[No Abstract] [Full Text] [Related]
8. Active specific immunotherapy of minimal residual tumor: excision plus neuraminidase-treated tumor cells.
Rios A; Simmons RL
Int J Cancer; 1974 Jan; 13(1):71-81. PubMed ID: 4818273
[No Abstract] [Full Text] [Related]
9. The combined effect of radiotherapy and neuraminidase-treated tumor cells on 3-methylcholanthrene-induced fibrosarcoma.
So SK; Song CW; Rios A; Simmons RL
J Surg Oncol; 1977; 9(6):527-40. PubMed ID: 592852
[TBL] [Abstract][Full Text] [Related]
10. Responses of tumors induced in inbred guinea pig strain JY=1 and strain Hartley/F to BCG.
Kataoka T; Tokunaga T; Murohashi T
J Natl Cancer Inst; 1977 Mar; 58(3):803-8. PubMed ID: 320348
[TBL] [Abstract][Full Text] [Related]
11. Experimental cancer immunotherapy using a neuraminidase-treated non-viable frozen tumor vaccine.
Rios A; Simmons RL
Surgery; 1974 Apr; 75(4):503-7. PubMed ID: 4840798
[No Abstract] [Full Text] [Related]
12. Neuraminidase treated cells and their role in cancer immunotherapy.
Simmons RL; Rios A
Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
[No Abstract] [Full Text] [Related]
13. Regression of established methylcholanthrene tumors by intratumor injections of Vbrio cholerae neuraminidase.
Simmons RL; Rios A; Ray PK
J Surg Oncol; 1972; 4(4):298-305. PubMed ID: 5083567
[No Abstract] [Full Text] [Related]
14. Failure of immunotherapy with neuraminidase-treated tumor cell vaccine in mice bearing established 3-methylcholanthrene-induced sarcomas.
Spence RJ; Simon RM; Baker AR
J Natl Cancer Inst; 1978 Feb; 60(2):451-9. PubMed ID: 621758
[TBL] [Abstract][Full Text] [Related]
15. Effect of oil-attached BCG cell-wall skeleton on the induction of pleural fibrosarcomas in mice.
Yoshimoto T; Azuma I; Sakatani M; Nishikawa H; Ogura T
Gan; 1976 Jun; 67(3):441-5. PubMed ID: 793922
[TBL] [Abstract][Full Text] [Related]
16. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
Simmons RL; Rios A
Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
[No Abstract] [Full Text] [Related]
17. Immunotherapy with neuraminidase-treated tumor cells after radiotherapy.
Song CW; Levitt SH
Radiat Res; 1975 Dec; 64(3):485-91. PubMed ID: 1197655
[No Abstract] [Full Text] [Related]
18. Cell surface modification in the treatment of experimental cancer: neuraminidase or concanavalin A.
Simmons RL; Rios A
Cancer; 1974 Oct; 34(4 Suppl):suppl:1541-7. PubMed ID: 4138077
[No Abstract] [Full Text] [Related]
19. Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase. II. Intratumor injections of neuraminidase.
Simmons RL; Rios A
Surgery; 1972 Apr; 71(4):556-64. PubMed ID: 5021071
[No Abstract] [Full Text] [Related]
20. Experimental and clinical trials with BCG immunotherapy.
Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
